Cargando…

A novel study on amyloid β peptide 40, 42 and 40/42 ratio in Saudi autistics

OBJECTIVES: We examined whether plasma concentrations of amyloid beta (Aβ) as protein derivatives play a central role in the etiology of autistic features. DESIGN AND METHODS: Concentrations of human Aβ (1-42), Aβ (1-40), and Aβ (40/42) in the plasma of 52 autistic children (aged 3-16 years) and 36...

Descripción completa

Detalles Bibliográficos
Autores principales: Al- Ayadhi, Laila Y, Ben Bacha, Abir G, Kotb, Malak, El-Ansary, Afaf K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3398286/
https://www.ncbi.nlm.nih.gov/pubmed/22239861
http://dx.doi.org/10.1186/1744-9081-8-4
_version_ 1782238266616971264
author Al- Ayadhi, Laila Y
Ben Bacha, Abir G
Kotb, Malak
El-Ansary, Afaf K
author_facet Al- Ayadhi, Laila Y
Ben Bacha, Abir G
Kotb, Malak
El-Ansary, Afaf K
author_sort Al- Ayadhi, Laila Y
collection PubMed
description OBJECTIVES: We examined whether plasma concentrations of amyloid beta (Aβ) as protein derivatives play a central role in the etiology of autistic features. DESIGN AND METHODS: Concentrations of human Aβ (1-42), Aβ (1-40), and Aβ (40/42) in the plasma of 52 autistic children (aged 3-16 years) and 36 age-matched control subjects were determined by using the ELISA technique and were compared. RESULTS: Compared to control subjects, autistic children exhibited significantly lower concentrations of both Aβ (1-40) and Aβ (1-42) and lower Aβ (40/42) concentration ratio. Receiver operating characteristics curve (ROC) analysis showed that these measurements of Aβ peptides showed high specificity and sensitivity in distinguishing autistic children from control subjects. CONCLUSIONS: Lower concentrations of Aβ (1-42) and Aβ (1-40) were attributed to loss of Aβ equilibrium between the brain and blood, an imbalance that may lead to failure to draw Aβ from the brain and/or impairment of β- and γ- secretase's concentration or kinetics as enzymes involving in Aβ production.
format Online
Article
Text
id pubmed-3398286
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33982862012-07-18 A novel study on amyloid β peptide 40, 42 and 40/42 ratio in Saudi autistics Al- Ayadhi, Laila Y Ben Bacha, Abir G Kotb, Malak El-Ansary, Afaf K Behav Brain Funct Research OBJECTIVES: We examined whether plasma concentrations of amyloid beta (Aβ) as protein derivatives play a central role in the etiology of autistic features. DESIGN AND METHODS: Concentrations of human Aβ (1-42), Aβ (1-40), and Aβ (40/42) in the plasma of 52 autistic children (aged 3-16 years) and 36 age-matched control subjects were determined by using the ELISA technique and were compared. RESULTS: Compared to control subjects, autistic children exhibited significantly lower concentrations of both Aβ (1-40) and Aβ (1-42) and lower Aβ (40/42) concentration ratio. Receiver operating characteristics curve (ROC) analysis showed that these measurements of Aβ peptides showed high specificity and sensitivity in distinguishing autistic children from control subjects. CONCLUSIONS: Lower concentrations of Aβ (1-42) and Aβ (1-40) were attributed to loss of Aβ equilibrium between the brain and blood, an imbalance that may lead to failure to draw Aβ from the brain and/or impairment of β- and γ- secretase's concentration or kinetics as enzymes involving in Aβ production. BioMed Central 2012-01-13 /pmc/articles/PMC3398286/ /pubmed/22239861 http://dx.doi.org/10.1186/1744-9081-8-4 Text en Copyright ©2012 Al- Ayadhi et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Al- Ayadhi, Laila Y
Ben Bacha, Abir G
Kotb, Malak
El-Ansary, Afaf K
A novel study on amyloid β peptide 40, 42 and 40/42 ratio in Saudi autistics
title A novel study on amyloid β peptide 40, 42 and 40/42 ratio in Saudi autistics
title_full A novel study on amyloid β peptide 40, 42 and 40/42 ratio in Saudi autistics
title_fullStr A novel study on amyloid β peptide 40, 42 and 40/42 ratio in Saudi autistics
title_full_unstemmed A novel study on amyloid β peptide 40, 42 and 40/42 ratio in Saudi autistics
title_short A novel study on amyloid β peptide 40, 42 and 40/42 ratio in Saudi autistics
title_sort novel study on amyloid β peptide 40, 42 and 40/42 ratio in saudi autistics
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3398286/
https://www.ncbi.nlm.nih.gov/pubmed/22239861
http://dx.doi.org/10.1186/1744-9081-8-4
work_keys_str_mv AT alayadhilailay anovelstudyonamyloidbpeptide4042and4042ratioinsaudiautistics
AT benbachaabirg anovelstudyonamyloidbpeptide4042and4042ratioinsaudiautistics
AT kotbmalak anovelstudyonamyloidbpeptide4042and4042ratioinsaudiautistics
AT elansaryafafk anovelstudyonamyloidbpeptide4042and4042ratioinsaudiautistics
AT alayadhilailay novelstudyonamyloidbpeptide4042and4042ratioinsaudiautistics
AT benbachaabirg novelstudyonamyloidbpeptide4042and4042ratioinsaudiautistics
AT kotbmalak novelstudyonamyloidbpeptide4042and4042ratioinsaudiautistics
AT elansaryafafk novelstudyonamyloidbpeptide4042and4042ratioinsaudiautistics